Organisation paid for research Program year 2025 Source: CMS Open Payments

AtlantiCare

Neither a doctor nor a teaching hospital

Research payments

$79,635

5 payments

Through program year 2025, AtlantiCare is reported as receiving $79,635 in research payments, across 5 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$77,653	3
2024	Research	$1,982	2

Breakdown

Who paid Research payments · program years 2024–2025

Pfizer Inc. $79,635 5 payments

Studies the money was for Research payments · program years 2024–2025

A Phase 3 Randomized Openlabel Study of Pf06821497 Mevrometostat in Combination With Enzalutamide Compared With Enzalutamide Or Docetaxel in Participants With Metastatic Castration Resistant Prostate Cancer Previously Treated With Abiraterone Acetate Mevpro1 $77,653 3 payments
A Phase 3 Randomized Openlabel Study of Pf06821497 Mevrometostat in Combination With Enzalutamide Compared With Enzalutamide Or Docetaxel in Participants With Metastatic Castration Resistant Prostate Cancer Previously Treated With Abiraterone Acetate Mevpro1 $1,982 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.